[EN] SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS<br/>[FR] PYRAZOLOAZÉPIN-4-ONES SUBSTITUÉES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE PHOSPHODIESTÉRASE
申请人:LEO PHARMA AS
公开号:WO2018108910A1
公开(公告)日:2018-06-21
The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents the treatment of inflammatory diseases and conditions.
本发明涉及具有磷酸二酯酶抑制活性的新型取代吡唑烯并-4-酮化合物,以及它们作为治疗炎症性疾病和症状的治疗剂的用途。